MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

A new law regulating gene technology in New Zealand is being passed under “Fast Track legislation” and will “bypass” ...

Researchers at the Technion-Israel Institute of Technology have discovered a unique genetic mechanism that provides cells with rapid and efficient protection against viruses. The findings could lead ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas ...

Genetic sequencing has gone through several advances ... Scientists have now used the more recent, long read technology to sequence far longer pieces of DNA. PacBio's HiFi sequencing can read about 20 ...

Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an adeno-associated virus vector serotype 9 (AAV9)-based gene therapy for retinal ...

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought ...

Researchers have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses ...

Regenxbio, a prolific developer of gene therapy technology, will hand Japan’s Nippon Shinyaku certain rights to two ...

Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space with its innovative gene therapy asset, ...

A research team led by Dr. Tetsuya Muramoto from the Faculty of Science at Toho University has demonstrated the mechanisms by which periodic chemical signal frequencies in cells regulate gene ...